Education:
- 2009 – Ph.D. in Immunology, Pasteur Institute.
- 2006 – Specialty in Infectology, INNSZ.
- 2004 – Specialty in HIV / AIDS, INNSZ.
- 1998 – Surgeon, National Autonomous University of Mexico.
Academic appointments:
- Assistant Professor, Department of medicine, Queen’s University.
- Researcher affiliated with CISIDAT.
Research interests:
- Infectious Immunopathogenesis.
- HIV AIDS
- HIV Cure
- COVID-19
SELECTED PUBLICATIONS
- Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load. Ruiz-Rivera MB, Gómez-Icazbalceta G, Vélez-Alavez M, Viveros-Rogel M, Pérez-Patrigeon S, Lamoyi E, Llorente L, Núñez-Álvarez CA, Huerta L. Immunol Lett. 2019 Jul;211:33-40.
- Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients. Sada-Ovalle I, Ocaña-Guzman R, Pérez-Patrigeón S, Chávez-Galán L, Sierra-Madero J, Torre-Bouscoulet L, Addo MM. J Int AIDS Soc. 2015 Oct 19;18:20078.
- Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection. Morán J, Ramírez-Martínez G, Jiménez-Alvarez L, Cruz A, Pérez-Patrigeon S, Hidalgo A, Orozco L, Martínez A, Padilla-Noriega L, Avila-Moreno F, Cabello C, Granados J, Ortíz-Quintero B, Ramírez-Venegas A, Ruíz-Palacios GM, Zlotnik A, Merino E, Zúñiga J. Exp Mol Pathol. 2015 Oct;99(2):253-61.
- Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones. Perez-Patrigeon S, Camiro-Zúñiga A, Jaramillo-Jante MR, Belaunzarán-Zamudio PF, Crabtree-Ramírez B, Soto-Ramírez LE, Calva JJ, Hernández-León C, Mosqueda-Gómez JL, Navarro-Alvarez S, Sierra-Madero JG. HIV Med. 2019 May;20(5):308-316. HIV Med. 2019 May;20(5):308-316.
- Pneumocystis jiroveci pneumonia and GATA2 deficiency: Expanding the spectrum of the disease. González-Lara MF, Wisniowski-Yáñez A, Pérez-Patrigeon S, Hsu AP, Holland SM, Cuellar-Rodríguez JM. J Infect. 2017 Apr;74(4):425-427.
- Lactic Acidosis Complicating Metformin and Non-Nucleoside Reverse Transcriptase Inhibitor Combination Therapy: A Smoldering Threat in the Post-HAART Era. Ortiz-Brizuela E, Pérez-Patrigeon S, Recillas-Gispert C, Gómez-Pérez FJ. Rev Invest Clin. 2015 Jul-Aug;67(4):273-4.
- Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. Galindo-Fraga A, Ortiz-Hernández AA, Ramírez-Venegas A, Vázquez RV, Moreno-Espinosa S, Llamosas-Gallardo B, Pérez-Patrigeon S, Salinger M, Freimanis L, Huang CY, Gu W, Guerrero ML, Beigel J, Ruiz-Palacios GM; La Red ILI 002 Study Group. Int J Infect Dis. 2013 Jul;17(7):e510-7.
- Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, Panuto J, Beasley RL, Perez-Patrigeon S, Suwanpimolkul G, Losso MH, McClure N, Bozzolo DR, Myers C, Holley HP Jr, Hoopes J, Lane HC, Hughes MD, Davey RT; IRC003 Study Team. Lancet Infect Dis. 2017 Dec;17(12):1255-1265.
- [Sepsis caused by methicillin-resistant Staphylococcus aureus: the shadow of a persistent threat]. Sifuentes-Osornio J, Pérez-Patrigeon S. Rev Invest Clin. 2006 Nov-Dec;58(6):598-607.
- A transcriptome-based model of central memory CD4 T cell death in HIV infection. Olvera-García G, Aguilar-García T, Gutiérrez-Jasso F, Imaz-Rosshandler I, Rangel-Escareño C, Orozco L, Aguilar-Delfín I, Vázquez-Pérez JA, Zúñiga J, Pérez-Patrigeon S, Espinosa E. BMC Genomics. 2016 Nov 22;17(1):956.